Back to Journals » Drug Design, Development and Therapy » Volume 14

Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis

Total article views   HTML views PDF downloads Totals
9,232 Dovepress* 7,977+ 1,383 9,360
PubMed Central* 1,255 398 1,653
Totals 9,232 1,781 11,013
*Since 14 January 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar